2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$93.50-$0.03 (-0.03%)
Price as of Aug 21, 2026 7:30 PM EDT- $4.6BMarket Cap
- 78.42%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$93.50-$0.03 (-0.03%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $93.53 | ||
Change | +$2.96 (+3.27%) | ||
Open | $91.39 | ||
High | $95.45 | ||
Low | $90.51 | ||
Previous Close | $90.57 | ||
Volume | 889,301 | ||
30-Day Average Volume | 1,011,177 | ||
1-Week Change | 1.66% | ||
1-Month Change | 2.01% | ||
1-Year Change | 78.42% | ||
3-Year Change | 837.17% | ||
5-Year Change | 339.31% | ||
Fundamentals | |||
Shares Outstanding | 48.9M | ||
Total Assets | $828.2M | ||
Market Cap | $4.6B | ||
Enterprise Value | $5.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.5M | ||
EBIT | $300,000.00 | ||
EBITDA | $359,000.00 | ||
Net Working Capital | $689.0M | ||
EPS | -$1.44 | ||
Enterprise Value/EBITDA | 14,339 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -65 | ||
PEG | 1 | ||
Price/Free Cash Flow | -82 | ||
Price/Operating Cash Flow | -83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue